Pipeline

18. January 2025

Pipeline

The recent published results of the ISAT-2 study draw a different view on the future of open microsurgical intervention for aSAH and on the therapeutic implications of its treatment with NicaPlant

20. August 2024

Pipeline

BIT Pharma announces the publication of an original investigation with the results of a randomized clinical trial with NicaPlant (Nicardipine Release Implants) for the prevention of vasospasm after Aneurysmal Subarachnoid Hemorrhage in JAMA Neurology.

4. October 2023

Pipeline

Phase 2a results published in Brain and Spine

22. May 2023

Pipeline

Phase 2 data with NicaPlant ® in aneurysmal subarachnoid haemorrhage patients will be presented at the XXVI Congress of Spanish Society of Neurosurgery (SENEC)

19. October 2022

Pipeline

European Medicines Agency Grants PRIME Designation to BIT Pharma’s NicaPlant® for Treatment of Non-traumatic Subarachnoid Haemorrhage in Patients undergoing Surgery.

31. August 2022

Pipeline

BIT Pharma Announces the Presentation of NicaPlant® Phase 2 Results at International Conferences

1. July 2022

Pipeline

BIT Pharma Announces Positive Phase 2b Study Results for NicaPlant® in Aneurysmal Subarachnoid Heamorrhage patients (aSAH) undergoing aneurysm clipping.

27. December 2019

Pipeline

NICAPLANT GRANTED ORPHAN MEDICINAL PRODUCT DESIGNATION

6. July 2019

Pipeline

BIT PHARMA ANNOUNCES SUCCESSFUL COMPLETION OF NicaPlant PHASE 2a CLINICAL TRIAL